Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

17.74
-0.0600-0.34%
Post-market: 17.800.0600+0.34%19:30 EDT
Volume:28.78K
Turnover:509.79K
Market Cap:104.67M
PE:- -
High:17.93
Open:17.89
Low:17.60
Close:17.80
52wk High:21.50
52wk Low:14.38
Shares:5.90M
Float Shares:5.90M
Volume Ratio:0.55
T/O Rate:0.49%
Dividend:0.71
Dividend Rate:4.03%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Wuxi Biologics (Cayman) Stock Climbs 1.7% in Hong Kong

Dow Jones
·
Sep 08

CSPC Pharmaceutical Group Stock Falls 2.7% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 08

Market Bets on BOJ Rate Hike While CICC's Merger Wins Regulatory Approval

Stock News
·
Sep 08

CSPC Pharma Begins Phase II Study of Influenza Drug in China

MT Newswires Live
·
Sep 07

Fourth Breakthrough Therapy Designation Granted to EGFR-Targeted ADC Developed by CSPC

Deep News
·
Sep 07

WuXi Biologics Files HKEX Next-Day Disclosure Return, Issues 1,804,090 New Shares

Reuters
·
Sep 07

CSPC Pharma Initiates Phase II Trial of SYH2085 Tablet for Uncomplicated Influenza in Chinese Adults

Stock News
·
Sep 07

Wuxi Biologics (Cayman) Stock Slides 1.4% in Hong Kong

Dow Jones
·
Sep 07

UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts

Stock News
·
Sep 07

Hong Kong Stock Connect Biotech Surges: Dual-Antibody Outperforms Keytruda, Sector Heats Up

Deep News
·
Sep 06

Loose Fed Bets and AI Monetization Fuel Hong Kong Stocks Rally

Stock News
·
Sep 04

WuXi Bio Issues 3.2 Million Shares Following Option Exercise

Stock News
·
Sep 04

Wall Street Cues, Easing Bond Yields Boost Asian Stock Markets

MT Newswires Live
·
Sep 04

Daiwa Highlights AKESO's HARMONi-2 Milestone, Bolstering Case for Global NSCLC Study Success

Stock News
·
Sep 04

Brokerage Adds Tencent and Innovent Bio to Buy List While Maintaining Positive Outlook on Tech and Hardware Sectors

Stock News
·
Sep 04

WuXi Biologics Files HKEX Next-Day Disclosure Return, Share Capital Rises by 2,423,900 Shares

Reuters
·
Sep 03

Wuxi Biologics (Cayman) Stock Advances 3.0% in Hong Kong

Dow Jones
·
Sep 03

CSPC Pharmaceutical Group Stock Climbs 4.8% in Hong Kong

Dow Jones
·
Sep 03

Clinical Data Readouts Take Center Stage as Chinese Biotech Firms Surge; CSPC Pharma Climbs Over 4% While Huabao's HK Biotech ETF Holds Key Support

Deep News
·
Sep 03

Akeso - Ivonescimab Meets Os Key Secondary Endpoint in Harmoni-2 Study

THOMSON REUTERS
·
Sep 03